SCHEMBL22927900

SCHEMBL22927900

CCCCCO[C@@H]1O[C@H](COC(C)=O)[C@H](OC(C)=O)[C@H](OC(C)=O)[C@@H]1NC(C)=O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 1/20 0.59
▸ MAPT P10636 1/20 0.59
▸ CYP2C9 P11712 1/20 0.59
▸ CYP2C19 P33261 1/20 0.59
▸ POLB P06746 2/20 0.56
▸ LMNA P02545 3/20 0.56
▸ KMT2A Q03164 1/20 0.56
▸ MAPK1 P28482 1/20 0.56
▸ ALDH1A1 P00352 2/20 0.55
▸ KDM4E B2RXH2 1/20 0.48
▸ CYP2D6 P10635 1/20 0.46
▸ THRB P10828 1/20 0.46
▸ HSD17B10 Q99714 1/20 0.46
▸ CA2 P00918 8/20 0.43
▸ CA12 O43570 7/20 0.43
▸ CA1 P00915 7/20 0.43
▸ CA9 Q16790 7/20 0.43
▸ TGM2 P21980 1/20 0.43
▸ BMP2 P12643 1/20 0.43
▸ VEGFA P15692 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14010319 1.00 CYP3A4 (0.59) CYP3A4MAPTCYP2C9CYP2C19POLB
SCHEMBL20334499 1.00 CYP3A4 (0.59) CYP3A4MAPTCYP2C9CYP2C19POLB
SCHEMBL4995717 1.00 CYP3A4 (0.59) CYP3A4MAPTCYP2C9CYP2C19POLB
SCHEMBL20516515 0.99 CYP3A4 (0.58) CYP3A4MAPTCYP2C9CYP2C19POLB
SCHEMBL20516521 0.99 CYP3A4 (0.58) CYP3A4MAPTCYP2C9CYP2C19POLB
SCHEMBL25480933 0.99 CYP3A4 (0.58) CYP3A4MAPTCYP2C9CYP2C19POLB
SCHEMBL20516500 0.99 CYP3A4 (0.58) CYP3A4MAPTCYP2C9CYP2C19POLB
SCHEMBL4989193 0.99 CYP3A4 (0.58) CYP3A4MAPTCYP2C9CYP2C19POLB
SCHEMBL10907272 0.99 CYP3A4 (0.58) CYP3A4MAPTCYP2C9CYP2C19POLB
SCHEMBL10907275 0.99 CYP3A4 (0.58) CYP3A4MAPTCYP2C9CYP2C19POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210023235-A1 BLOCK COPOLYMERS GENEVANT SCIENCES GMBH (CH) 2021-01-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210023235-A1 BLOCK COPOLYMERS CHMP4B, CD47, EEA1 CYP3A4 4778/4885MAPT 3528/4885CYP2C9 4865/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback